Advanced search

New treatment options in spondyloarthropathies : increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Braun, J, Filip De Keyser, J Brandt, Herman Mielants, J Sieper, and Eric Veys. 2001. “New Treatment Options in Spondyloarthropathies : Increasing Evidence for Significant Efficacy of Anti-tumor Necrosis Factor Therapy.” Current Opinion in Rheumatology 13 (4): 245–249.
APA
Braun, J, De Keyser, F., Brandt, J., Mielants, H., Sieper, J., & Veys, E. (2001). New treatment options in spondyloarthropathies : increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. CURRENT OPINION IN RHEUMATOLOGY, 13(4), 245–249.
Vancouver
1.
Braun J, De Keyser F, Brandt J, Mielants H, Sieper J, Veys E. New treatment options in spondyloarthropathies : increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. CURRENT OPINION IN RHEUMATOLOGY. 2001;13(4):245–9.
MLA
Braun, J, Filip De Keyser, J Brandt, et al. “New Treatment Options in Spondyloarthropathies : Increasing Evidence for Significant Efficacy of Anti-tumor Necrosis Factor Therapy.” CURRENT OPINION IN RHEUMATOLOGY 13.4 (2001): 245–249. Print.
@article{169558,
  author       = {Braun, J and De Keyser, Filip and Brandt, J and Mielants, Herman and Sieper, J and Veys, Eric},
  issn         = {1040-8711},
  journal      = {CURRENT OPINION IN RHEUMATOLOGY},
  language     = {eng},
  number       = {4},
  pages        = {245--249},
  title        = {New treatment options in spondyloarthropathies : increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.},
  volume       = {13},
  year         = {2001},
}

Web of Science
Times cited: